• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

63.59 +1.34 (+2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,458,316
Open 63.14
Bid (Size) 61.00 (2)
Ask (Size) 64.50 (1)
Prev. Close 62.25
Today's Range 61.69 - 63.99
52wk Range 29.31 - 64.13
Shares Outstanding 95,640,600
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
October 31, 2025
From Schall Law
Via GlobeNewswire
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
October 31, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit

Performance

YTD
+30.0%
+30.0%
1 Month
+13.9%
+13.9%
3 Month
+73.3%
+73.3%
6 Month
+70.3%
+70.3%
1 Year
+24.7%
+24.7%

More News

Read More
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
October 31, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
October 30, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK
October 30, 2025
From Pomerantz LLP
Via GlobeNewswire
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
October 30, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
October 30, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
October 29, 2025
From SkyMedia, LLC
Via GlobeNewswire
CYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds CYTK Investors to Contact the Firm Before November 17th
October 29, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 29, 2025
Via NewMediaWire
Topics Fraud Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 29, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
October 29, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
October 29, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
October 28, 2025
From Kahn Swick & Foti, LLC
Via GlobeNewswire
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
October 28, 2025
From Schall Law
Via GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Cytokinetics, Incorporated (CYTK) of a Class Action Lawsuit and an Upcoming Deadline
October 28, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Levi & Korsinsky Notifies Shareholders of Cytokinetics, Incorporated (CYTK) of a Class Action Lawsuit and an Upcoming Deadline
October 28, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
October 26, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
CYTOKINETICS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Cytokinetics Investors of the Filed Class Action Lawsuit and Urges Investors to Contact the Firm Before November 17th
October 25, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline
October 24, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK
October 24, 2025
From Pomerantz LLP
Via GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 23, 2025
Via NewMediaWire
Topics Fraud Lawsuit
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 23, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CYTK
October 23, 2025
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CYTK
October 23, 2025
Via TheNewswire.com
Topics Earnings Fraud Lawsuit

Frequently Asked Questions

Is Cytokinetics, Incorporated - Common Stock publicly traded?
Yes, Cytokinetics, Incorporated - Common Stock is publicly traded.
What exchange does Cytokinetics, Incorporated - Common Stock trade on?
Cytokinetics, Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytokinetics, Incorporated - Common Stock?
The ticker symbol for Cytokinetics, Incorporated - Common Stock is CYTK on the Nasdaq Stock Market
What is the current price of Cytokinetics, Incorporated - Common Stock?
The current price of Cytokinetics, Incorporated - Common Stock is 63.59
When was Cytokinetics, Incorporated - Common Stock last traded?
The last trade of Cytokinetics, Incorporated - Common Stock was at 10/31/25 04:00 PM ET
What is the market capitalization of Cytokinetics, Incorporated - Common Stock?
The market capitalization of Cytokinetics, Incorporated - Common Stock is 6.08B
How many shares of Cytokinetics, Incorporated - Common Stock are outstanding?
Cytokinetics, Incorporated - Common Stock has 6B shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap